Caitlin Pelan is a Boston, Massachusetts based nurse practitioner. Active license number of Caitlin Pelan is RN2372874 for Critical Care Medicine in Massachusetts. Her current practice location is 55 Fruit St, Boston. Patients can reach her at 617-726-2000. Caitlin Pelan is CNP, CCRN and her NPI number (Unique professional ID assigned by NPPES) is 1255887196. Caitlin Pelan has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Caitlin Pelan speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1255887196
NPI Enumeration Date:
31 Aug, 2016
NPI Last Update On:
21 Nov, 2022
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Caitlin Pelan are as mentioned below.
License Number
Specialization
State
Status
RN2372874
Critical Care Medicine
Massachusetts
Primary
719654
Registered Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Caitlin Pelan 55 Fruit St, Boston, Massachusetts
Zip:
02114-2621
Patients can reach Caitlin Pelan at 55 Fruit St, Boston, Massachusetts or can call to book an appointment on 617-726-2000.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 10 March, 2025.